Hims & Hers Health Announces $300M Convertible Notes Offering to Fund International Expansion and AI Investment
Hims & Hers Health plans to raise $300 million through a convertible senior notes offering as it prepares for international expansion, including its proposed acquisition of Eucalyptus. The company said proceeds will also support investments in AI capabilities, fulfillment infrastructure, and operational efficiencies.
INDUSTRY
Editor
5/19/20261 min read
Hims & Hers Health has announced plans to offer $300 million in convertible senior notes due 2032 through a private placement to qualified institutional buyers. The company also expects to grant initial purchasers an option to buy up to an additional $45 million in notes.
The proceeds are intended to support the company’s international expansion strategy, including the proposed acquisition of Australian telehealth platform Eucalyptus, which Hims & Hers expects to close in mid-2026 subject to customary conditions. The company said it also plans to invest in technology and fulfillment infrastructure to improve operational efficiency and expand AI capabilities across its platform.
The financing follows a challenging period for Hims & Hers, with the company facing increased scrutiny around aspects of its compounded GLP-1 weight loss business and broader questions about the sustainability of telehealth-driven obesity treatment models. Against that backdrop, the offering provides additional balance sheet flexibility as the company expands internationally and continues investing heavily in infrastructure and AI capabilities.
Hims & Hers said its AI investments will focus on enhancing the consumer experience and making greater use of its “closed-loop data ecosystem.” Part of the proceeds will also fund capped call transactions designed to reduce potential shareholder dilution from future note conversions.
At $300 million, the proposed offering also stands out as one of the larger recent capital raises connected to the men’s health and digital health sectors. The financing underscores continued investor appetite for scaled consumer health platforms despite broader volatility across the telehealth and digital health markets.